Turfan, Xinjiang: Accelerating Construction of 10-Million-Kilowatt-Level New Energy Base
TURFAN, China, June 11, 2025 /PRNewswire/ -- On June 11th, Turfan's installed capacity of new energy sources reached 9.035 million kilowatts (kW), accounting for 74.2% of its total power generation capacity. The region is expected to complete the...
Ampace Andes Powers Through Extreme Challenges at 7,000 Meters on Mount Everest
NEW YORK, June 10, 2025 /PRNewswire/ -- Veteran mountaineer and extreme landscape photographer Gao Li—marking his tenth year of Himalayan expeditions—recently reached Mount Everest's summit (8,848.86m) for the third time. An accomplished explorer of...
The installed capacity of new energy in Turfan has surpassed 9 million kilowatts, accounting for 74.2% of the total installed capacity of power sources
TURFAN, China, May 29, 2025 /PRNewswire/ -- On May 29th, State Grid Turfan Power Supply Company announced that the installed capacity of new energy in Turfan reached 9.035 million kilowatts, representing 74.2% of the total installed capacity of...
Visionary Holdings' Changle Shuang Carries Out Biotechnology Health Public Welfare Activities for Society
TORONTO, May 27, 2025 /PRNewswire/ -- On May 23, 2025, Changle Shuang, a subsidiary of Visionary Holdings (Nasdaq: GV), officially reached a strategic partnership with the Guangzhou Jianjia Charity Foundation in Guangzhou. The two parties signed a...
Poised to Reshape Treatment Landscape: The Phase 3 Clinical Trial of Disitamab Vedotin as a First-Line Therapy for HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma Reached its Primary Endpoints of PFS and OS
YANTAI, China, May 12, 2025 /PRNewswire/ -- On May 12th, 2025, RemeGen Co., Ltd. ("RemeGen", stock symbols: 688331.SH/09995.HK) announced that its phase 3 clinical trial (Study ID: RC48-C016) on disitamab vedotin (DV, brand name: 爱地希®), the first...
The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
The results showed that the SOFA scores of the drug treatment groups on the 7th day were significantly lower than those of the baseline, especially in the high-dose group, where the decrease was significantly greater than that in the placebo group,...
Thailand's First Quarter Investment Applications Almost Double to 431.2 Billion Baht Boosted by Fivefold Increase in Digital Sector, BOI Says
BANGKOK, April 30, 2025 /PRNewswire/ -- The value of applications for investment promotion in Thailand in the first quarter of 2025 amounted to 431.2 billion baht (USD 12.9 billion), an increase of 97% from the same period of last year, led by large...
WuXi AppTec Q1 2025 Revenue, Profit Resume Double Digit Growth, Revenue Up 21.0% YoY, Adjusted Non-IFRS Net Profit Up 40.0% YoY; Backlog for Continuing Operations Up 47.1% YoY
Total Revenue Reached RMB9.65 Billion, Up 21.0% Year-over-Year; among which Revenue from Continuing Operations Reached RMB9.39 Billion, Up 23.1% Year-over-Year Net Profit Attributable to the Owners of the Company Reached RMB3.67 Billion [1] , Up...
CHAGEE & FLUX Technology: Empower Global Expansion with Digital Intelligence
SHANGHAI, April 18, 2025 /PRNewswire/ -- Recently, CHAGEE, a Chinese tea brand, has reached a cooperation with FLUX Technology and introduced the FLUX TMS to create a digital and intelligent transportation and distribution system. On the evening of...
Baijiayun and Xinlantian Reached Strategic Cooperation to Use AI Technology to Assist the Rehabilitation of Tens of Millions of Autistic Children
BEIJING, April 17, 2025 /PRNewswire/ -- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC), a one-stop AI video solution provider, today announced that we have reached a strategic cooperation with Beijing Xinlantian Education...